Annual report pursuant to Section 13 and 15(d)

Stockholders' Equity - Additional Information (Details)

v3.22.1
Stockholders' Equity - Additional Information (Details) - USD ($)
$ / shares in Units, $ in Thousands
 1 Months Ended 12 Months Ended
Feb. 16, 2018
Dec. 31, 2021
Nov. 30, 2021
Dec. 31, 2021
Dec. 31, 2020
Sep. 13, 2016
Preferred Stock, Shares Authorized   2,000,000   2,000,000 2,000,000 2,000,000
Common Stock, Shares Authorized   50,000,000   50,000,000 50,000,000  
Common Stock, Par or Stated Value Per Share   $ 0.0001   $ 0.0001 $ 0.0001  
Number of units issued   1,910,100 2,238,805      
Price per share   $ 1.07 $ 1.34 $ 1.07    
Gross proceeds from initial public offering before deducting expenses   $ 2,000 $ 3,000      
Number of days granted options to purchase underwriter   45 days        
Percentage of additional shares issued to underwriters   15.00%        
Net proceeds from this underwritten public offering   $ 1,800 $ 2,600      
Share-based Compensation       $ 442 $ 710  
Preferred Stock, Par or Stated Value Per Share   $ 0.0001   $ 0.0001 $ 0.0001  
Two Thousand Fifteen Incentive Plan            
Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Authorized   4,000,000   4,000,000    
Share-based Compensation Arrangement by Share-based Payment Award, Expiration Period       10 years    
Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Available for Grant   1,827,336   1,827,336    
Fortress Biotech Inc            
Percentage of Diluted outstanding Equity 2.50%          
Restricted Stock Units and Restricted Stock Awards            
Share-based Compensation       $ 400 $ 700  
Employee Service Share-based Compensation, Nonvested Awards, Compensation Not yet Recognized, Share-based Awards Other than Options   $ 700   $ 700    
Employee Service Share-based Compensation, Nonvested Awards, Compensation Cost Not yet Recognized, Period for Recognition       9 months 3 days    
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested Upon Performance       50,000    
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value       $ 0.93 $ 10.99  
Weighted Average Grant Date Fair Value, Forfeited       $ 7.98 $ 0  
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period, Fair Value       $ 600 $ 500  
Options | Two Thousand Fifteen Incentive Plan            
Share-based Compensation Arrangement by Share-based Payment Award, Terms of Award       10 years    
Class A Preferred Shares            
Preferred Stock, Shares Outstanding   250,000   250,000 250,000 250,000
Preferred Stock, Par or Stated Value Per Share           $ 0.0001